SCHEMBL4498586

SCHEMBL4498586

[CH2]CCc1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 7/20 0.46
TSHR P16473 6/20 0.46
CYP3A4 P08684 4/20 0.46
TTR P02766 3/20 0.46
RECQL P46063 3/20 0.46
ALDH1A1 P00352 2/20 0.46
THRB P10828 3/20 0.42
ALOX15 P16050 4/20 0.41
CYP2C9 P11712 3/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
ALOX12 P18054 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HIF1A Q16665 3/20 0.41
CYP2D6 P10635 2/20 0.39
DBH P09172 1/20 0.38
HPGD P15428 4/20 0.37
MAPK1 P28482 3/20 0.37
MEN1 O00255 2/20 0.37
EGFR P00533 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7885118 0.85 HSD17B10 (0.55) HSD17B10TSHRCYP3A4TTRRECQL
SCHEMBL9293760 0.80 ALDH1A1 (0.41) HSD17B10TSHRCYP3A4RECQLALDH1A1
SCHEMBL2415959 0.80 HSD17B10 (0.50) HSD17B10TSHRCYP3A4TTRRECQL
SCHEMBL10971449 0.78 IGF1R (0.46) HSD17B10TSHRCYP3A4TTRRECQL
SCHEMBL2927011 0.78 HSD17B10 (0.48) HSD17B10TSHRCYP3A4TTRRECQL
SCHEMBL15517328 0.78 PNMT (0.32)
SCHEMBL15517336 0.76 PNMT (0.31) CYP2C9CYP1A2CYP2C19CYP2D6
SCHEMBL445337 0.76 HSD17B10 (0.46) HSD17B10TSHRCYP3A4TTRRECQL
SCHEMBL1469394 0.76 TAAR1 (0.56) HSD17B10TSHRCYP3A4TTRRECQL
SCHEMBL6809958 0.76 HSD17B10 (0.46) HSD17B10TSHRCYP3A4TTRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318429-A1 Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives INSTITUTE FOR ONEWORLD HEALTH 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318429-A1 Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives CFTR, PKD1, PKD2 HSD17B10 1275/4885TSHR 2802/4885CYP3A4 1541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.